251 related articles for article (PubMed ID: 16480980)
21. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination.
Lindner M; Trebst C; Heine S; Skripuletz T; Koutsoudaki PN; Stangel M
Glia; 2008 Aug; 56(10):1104-13. PubMed ID: 18442092
[TBL] [Abstract][Full Text] [Related]
22. Expression of an acyl-CoA synthetase, lipidosin, in astrocytes of the murine brain and its up-regulation during remyelination following cuprizone-induced demyelination.
Song SY; Kato C; Adachi E; Moriya-Sato A; Inagawa-Ogashiwa M; Umeda R; Hashimoto N
J Neurosci Res; 2007 Dec; 85(16):3586-97. PubMed ID: 17722065
[TBL] [Abstract][Full Text] [Related]
23. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity.
Parenti R; Cicirata F; Zappalà A; Catania A; La Delia F; Cicirata V; Tress O; Willecke K
Glia; 2010 Oct; 58(13):1594-609. PubMed ID: 20578039
[TBL] [Abstract][Full Text] [Related]
24. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
25. Implications of protease M/neurosin in myelination during experimental demyelination and remyelination.
Bando Y; Ito S; Nagai Y; Terayama R; Kishibe M; Jiang YP; Mitrovic B; Takahashi T; Yoshida S
Neurosci Lett; 2006 Sep; 405(3):175-80. PubMed ID: 16890353
[TBL] [Abstract][Full Text] [Related]
26. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
[TBL] [Abstract][Full Text] [Related]
27. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination.
Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H
J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413
[TBL] [Abstract][Full Text] [Related]
28. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Steelman AJ; Thompson JP; Li J
Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
[TBL] [Abstract][Full Text] [Related]
30. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
Paez PM; Cheli VT; Ghiani CA; Spreuer V; Handley VW; Campagnoni AT
Glia; 2012 Jul; 60(7):1078-93. PubMed ID: 22447683
[TBL] [Abstract][Full Text] [Related]
31. Apotransferrin induces cAMP/CREB pathway and cell cycle exit in immature oligodendroglial cells.
Garcia C; Paez P; Davio C; Soto EF; Pasquini JM
J Neurosci Res; 2004 Nov; 78(3):338-46. PubMed ID: 15389838
[TBL] [Abstract][Full Text] [Related]
32. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
Clarner T; Parabucki A; Beyer C; Kipp M
J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085
[TBL] [Abstract][Full Text] [Related]
33. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination.
Millet V; Marder M; Pasquini LA
Exp Neurol; 2012 Jan; 233(1):490-504. PubMed ID: 22155618
[TBL] [Abstract][Full Text] [Related]
34. Demyelination increases radial diffusivity in corpus callosum of mouse brain.
Song SK; Yoshino J; Le TQ; Lin SJ; Sun SW; Cross AH; Armstrong RC
Neuroimage; 2005 May; 26(1):132-40. PubMed ID: 15862213
[TBL] [Abstract][Full Text] [Related]
35. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
Briggs DT; Martin CB; Ingersoll SA; Barnum SR; Martin BK
Glia; 2007 Nov; 55(14):1405-15. PubMed ID: 17674370
[TBL] [Abstract][Full Text] [Related]
36. Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse.
Sun X; Liu Y; Liu B; Xiao Z; Zhang L
Exp Neurol; 2012 Oct; 237(2):304-11. PubMed ID: 22836144
[TBL] [Abstract][Full Text] [Related]
37. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
[TBL] [Abstract][Full Text] [Related]
38. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
Komoly S
Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity.
Ludwin SK
Lab Invest; 1978 Dec; 39(6):597-612. PubMed ID: 739762
[TBL] [Abstract][Full Text] [Related]
40. The Role of Galectin-3: From Oligodendroglial Differentiation and Myelination to Demyelination and Remyelination Processes in a Cuprizone-Induced Demyelination Model.
Hoyos HC; Marder M; Ulrich R; Gudi V; Stangel M; Rabinovich GA; Pasquini LA; Pasquini JM
Adv Exp Med Biol; 2016; 949():311-332. PubMed ID: 27714696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
